Leronlimab corrects the immune system. Dr. Harish Seethamraju called, he says, "your product has indication inflammation not just [rantes cause] down. That's one aspect. Dont put all your focus on rantes. Its a lot more than that." And it's something corrects the immune system. That's why this is so many different uses.

Did we talk about this? From Dr. Seethamraju take of Leronlimab.

Did we discuss market implications? Value? I missed that conversation the other day.